📢 PUBLICATION ALERT The #WASHOUT protocol is out 🥳 🤔 #Haematuria = ~15% of emergency urology admissions with ⏫ variation in practice & resource use 🥇This is the FIRST international study to map how haematuria is managed globally 🤯 🔗 https://t.co/RA9Jrjj9kC #UroSoMe

Great to be a part of this seminal Trial 🙌🏽

Listen to @profgalloway. Noble pays you to get off your phone. Join today for $100 cash back bonus.

📢 Meet some of our new ELIPSE–BURST Associate PIs! Interested in joining the network? 👩‍⚕️👨‍⚕️ Contact @BURSTUrology to find out more!

⭐️ Introducing our Chairs for tomorrow’s webinar on systemic anti-cancer treatment in metastatic prostate cancer, Dr @alison_tree and Professor Noel Clarke, Clinical Leads @NPCA_uk 🎟️ Last chance to join us 9am tomorrow https://t.co/sU7JhrQkV7 #UroSoMe

⌛️ONE DAY until our webinar with @NPCA_uk on systemic anti-cancer treatment in metastatic prostate cancer 🎤 We’re thrilled to welcome Dr Justin Liu who will be going through case studies ⏰ 9am 23rd Oct There’s still time to register! 👇 🔗 https://t.co/sU7JhrQkV7 #UroSoMe

Looking forward to our webinar with @BURSTurology More details can be found on our website https://t.co/mROoucmJ0r Find your sMDT's results on our data dashboard https://t.co/SAPmpONOwN and more details in our State of the Nation Report 2025

‼️ TWO DAYS until our webinar with @NPCA_uk 9am 23 Oct 🎤 We’re thrilled to welcome Mr El-Taji @UroTaji who will be discussing cardiovascular and bone health in prostate cancer: mitigating the effects of ADT ± ARPIs Final spots remaining👇 🔗 https://t.co/sU7JhrQSKF #UroSoMe

UATX will never charge tuition. And we will never take government money. Here's why. Graduates spend decades shouldering debt for hollow credentials. This debt influences every decision they make: What job to take. Where to live. When to marry. When to have children. Some will

⌛️The countdown is on for 9am 23rd Oct for our webinar with @NPCA_uk on systemic anti-cancer treatment in metastatic prostate cancer 🎤 We’re thrilled to welcome Ms Diana Matthews, speaking on safe ARPI prescribing, common pitfalls and interactions 🔗 https://t.co/sU7JhrQkV7

Sign up for our webinar on 23.10.25 at 09.00 👇 https://t.co/09GaCKNa5y

📩 This week’s BAUS newsletter is in members' inboxes and via MyBAUS. Highlights include: 🎙️BAUS Talks: Beyond the Cystoscope podcast w/ @AnkurMuk @hayesjdb @BSoT_UK 🖥️@BURSTurology webinar on #prostate #cancer 🌍Various regional meetings 🗳️@UrolinkUrology member survey

🗓️ Join us 9am 23rd Oct for our webinar with @NPCA_uk on the use of systemic anti-cancer treatment in metastatic prostate cancer! 🎤  We are thrilled to welcome @PasRescigno who will discuss the evidence for the use of ARPIs 🔗Sign up https://t.co/CfMFpEKIXq   #UroSoMe

Now available by popular demand.

🤔 Got a question about the use of systemic anti-cancer treatment in metastatic prostate cancer? The @NPCA_uk is here to help! Submit your questions and our expert panel will answer them in our webinar on 23 Oct 9am👉 https://t.co/gACnN369lD   🔗 https://t.co/CfMFpELgMY

📝 Submit abstracts: https://t.co/cgGS2pN4g4 🎟️ Register: https://t.co/hMQt7mWJCu ℹ️ More info: https://t.co/46veu9ZsLZ #GreenerFuture #UroSoMe

🌱 Research for #GreenerSurgery Conference 2025 📅 17 Dec 2025 | 🏛️ The Great Hall, University of Birmingham Dedicated to advancing #sustainable surgical practice, connecting #surgeons, #researchers and #healthcare professionals Links below 👇

Excited to partner with ELIPSE to advance research that will improve care & outcomes for prostate cancer patients in the UK and worldwide. 🌎

We built FXR Script to give indicator developers a new way to create, share, and reach traders worldwide. With a few lines of code, any trader can create world-class indicators for backtesting. Huge props to @outof0ptions for launching EIGHT new indicators directly on our

@BURSTurology @NPCA_uk @alison_tree @UroTaji @PasRescigno @BAUSurology @ESRUrology @ArjunSNathan Great line up - 👀 you there

👇The programme for our webinar with @NPCA_uk on the use of systemic anti-cancer treatment in metastatic prostate cancer on 23 Oct 9am 🧬Evidence for use of ARPIs 💊Safe prescribing 🫀CV and bone health- mitigating effects of ADT ±ARPIs 🔎Case studies  🔗 https://t.co/sU7JhrQSKF

We have a fully funded 3 yr PhD post @ucl, deadline 12th Nov. Research is on optimising prostate cancer diagnosis using imaging (e.g MRI, PET, AI). Join our world-class team with proven track-record 4 changing practice. https://t.co/tlNQBaqxu9 @BURSTurology @BSUroRad @ESRUrology

We're excited to be joining forces with @BURSTurology to bring you this webinar, as part of our QI Intervention. Hosted by our excellent clinical leads @alison_tree and Noel Clarke, and featuring our newest clinical fellow, Justin Liu, who will be presenting some case studies.

🚀 We are delighted to announce our upcoming webinar with @NPCA_uk - “The use of systemic anti-cancer treatment in metastatic prostate cancer.”  🗓️ Join us on 23rd Oct for an evidence-based update on systemic therapy in metastatic prostate cancer 🔗 https://t.co/CfMFpELgMY

4/n World class faculty including @giga_fra, Clare Allen, Louise Dickinson, Mark Emberton, Zaf Tandogdu, John Withington, Anita Mitra @ButeauJames, @GiorgioBre, Maarten de Rooij, Jurgen Futterer, Lars Budaus, @JGomezRivas, @aimhaider, Ivo Schoots, Vibeke Logager & many more